We included 50 ESCC patients who underwent radical radiotherapy and chemotherapy in the treatment center to detect tumor markers in peripheral blood, mainly including AFP, CEA, CA19-9, CA72-4, NSE and CYFRA21-1. This evidence concerns the gene ENO2 and esophageal squamous cell carcinoma.